Find Clinical Trial
Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life in Patients with Metastatic Colorectal Cancer
← Back
| Study Phase |
Phase 4 |
| Therapeutic Area |
Cancers |
| Indication | Solid tumors |
| Sponsor | Servier Deutschland GmbH |
| Active substance/ Medical device |
TIPIRACIL, TRIFLURIDINE, |
| Active Substance Code | S095005 |
| Protocol Code | IC4-95005-183-DEU |
| EudraCT Code | 2017-000292-83 |
| ISRCTN Code | ISRCTN90009147 |
| Other Protocol Name : | Tallisur DRKS00012977 |
Documents and links
| Results are not yet available. |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information
Report a side-effect with a drug.
All Rights Reserved. Servier does not sell its products over the Internet.
More information
Report a side-effect with a drug.
Accessibility
